FDA Authorizes Use of AI-Powered Medical Device to Detect the Most Common Skin Cancers

The Food and Drug Administration (FDA) has authorized the first-of-its-kind non-invasive artificial intelligence-powered medical device to detect three of the most common skin cancers in real time. The FDA said on Jan. 16 that it had cleared the DermaSensor Inc. device, made by the Miami-based company of the same name, to be used by physicians on patients aged 40 and over. According to DermaSensor Inc., the wireless, handheld device uses spectroscopy (the absorption and emission of light and other radiation by matter) and FDA-cleared algorithms to evaluate cellular and subcellular characteristics of a skin lesion to identify potential cancer cells in seconds. Typically, skin cancer is identified through a procedure known as dermatoscopy, in which a medical professional examines the skin for signs of cancer using a specialized magnifying glass or through a visual examination....